Abstract
PET and PET/CT, using 18F-fluoro-2-deoxy-D-glucose, are not suited for primary diagnostics of small tumours or lymph node metastases to the axilla. In return, the method has a high sensitivity and specificity regarding the detection of loco-regional recurrence and metastases to mediastinal lymph nodes, bones, liver and lungs. Whether the method can replace the conventional evaluation or be a supplement if conventional evaluation is non-conclusive, remains unresolved. PET/CT has a clear advantage compared to PET alone and will probably find increasing use in the treatment planning and evaluation of patients with breast cancer.
| Bidragets oversatte titel | [Indications for the use of PET or PET/CT in patients with breast cancer] |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 173 |
| Udgave nummer | 42 |
| Sider (fra-til) | 2638-41 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 2011 |
Emneord
- Breast Neoplasms
- Female
- Fluorodeoxyglucose F18
- Humans
- Lymphatic Metastasis
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Positron-Emission Tomography
- Radiopharmaceuticals
- Sensitivity and Specificity